Description
Temoside Temozolomide 100mg Capsules: A Comprehensive Overview
Temoside Temozolomide 100mg Capsules contain Temozolomide, an oral chemotherapy drug classified as an alkylating agent. Doctors use this medication specifically for treating certain primary brain tumors, such as glioblastoma multiforme (GBM) and anaplastic astrocytoma. The medication is highly effective because it can cross the blood-brain barrier (BBB). Temozolomide works by undergoing non-enzymatic chemical conversion in the body to its active form, which then damages the DNA of cancer cells. In essence, it adds methyl groups to the DNA, primarily at the O$^6$ position of guanine. This damage leads to DNA mismatches and triggers a ‘futile repair cycle’ within the cell. Consequently, this action prevents the cancer cells from growing and replicating, ultimately inducing programmed cell death (apoptosis).
Usage, Administration, and Therapeutic Protocols
Cipla manufactures Temoside, and a doctor typically administers it under medical supervision in cycles. The standard treatment protocol often includes two phases:
-
Concomitant Phase: The patient takes the medication daily alongside radiation therapy for several weeks (e.g., 42-49 days).
-
Maintenance Phase: This follows a rest period, where the patient takes the drug for 5 days of a 28-day cycle, typically for up to six cycles.
The precise dosage is highly individualized. Furthermore, it depends on the patient’s body surface area, overall condition, and the specific treatment protocol (newly diagnosed or recurrent tumor). It is crucial for patients to follow the prescribed dosage schedule strictly and swallow the capsules whole, usually on an empty stomach, to ensure maximum treatment efficacy and absorption.
Manufacturing, Safety, and Monitoring
Common side effects of Temoside may include nausea, vomiting, fatigue, and decreased blood counts (myelosuppression), particularly low white blood cells (neutropenia) and platelets (thrombocytopenia). Myelosuppression is a serious, dose-limiting toxicity that increases the risk of infection and bleeding. For this reason, doctors consider regular blood monitoring essential during the course of therapy. To that end, they perform complete blood counts (CBC) weekly during the concomitant phase and frequently during the maintenance cycles to ensure the patient’s blood cell levels are safe before the next dose is administered.
Availability & Purchase Information
Genetec Lifesciences makes Temoside Temozolomide 100mg Capsules available. We source directly from Cipla or their authorized distributors. For bulk purchase or export inquiries, please reach out to our team.
Disclaimer
This site provides product information for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or authorized vendors of the company.